Medical Journals

Prostaglandin D2-mediated Microglia/Astrocyte Interaction Enhances Astrogliosis and Demyelination in Twitcher.

Authors:
  • Mohri Ikuko
  • Taniike Masako
  • Taniguchi Hidetoshi
  • Kanekiyo Takahisa
  • Aritake Kosuke
  • Inui Takashi
  • Fukumoto Noriko
  • Eguchi Naomi
  • Kushi Atsuko
  • Sasai Hitoshi
  • Kanaoka Yoshihide
  • Ozono Keiichi
  • Narumiya Shuh
  • Suzuki Kinuko
  • Urade Yoshihiro

From: Department of Developmental Medicine (Pediatrics), Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan.

The Journal of neuroscience : the official journal of the Society for Neuroscience

  • Publish Date: Apr 2006
  • ISSN: 1529-2401
  • Volume: 26
  • Issue: 16
  • Pages: 4383-93
  • Medium: Internet
  • Language: English
  • Citation (JAMA): Mohri Ikuko, Taniike Masako, Taniguchi Hidetoshi, et al. Prostaglandin D2-mediated Microglia/Astrocyte Interaction Enhances Astrogliosis and Demyelination in Twitcher.. J. Neurosci. Apr 2006;26:4383-93

Abstract

Prostaglandin (PG) D2 is well known as a mediator of inflammation. Hematopoietic PGD synthase (HPGDS) is responsible for the production of PGD2 involved in inflammatory responses. Microglial activation and astrogliosis are commonly observed during neuroinflammation, including that which occurs during demyelination. Using the genetic demyelination mouse twitcher, a model of human Krabbe’s disease, we discovered that activated microglia expressed HPGDS and activated astrocytes expressed the DP1 receptor for PGD2 in the brain of these mice. Cultured microglia actively produced PGD2 by the action of HPGDS. Cultured astrocytes expressed two types of PGD2 receptor, DP1 and DP2, and showed enhanced GFAP production after stimulation of either receptor with its respective agonist. These results suggest that PGD2 plays an important role in microglia/astrocyte interaction. We demonstrated that the blockade of the HPGDS/PGD2/DP signaling pathway using HPGDS- or DP1-null twitcher mice, and twitcher mice treated with an HPGDS inhibitor, HQL-79 (4-benzhydryloxy-1-[3-(1H-tetrazol-5-yl)-propyl]piperidine), resulted in remarkable suppression of astrogliosis and demyelination, as well as a reduction in twitching and spasticity. Furthermore, we found that the degree of oligodendroglial apoptosis was also reduced in HPGDS-null and HQL-79-treated twitcher mice. These results suggest that PGD2 is the key neuroinflammatory molecule that heightens the pathological response to demyelination in twitcher mice.

Mesh Headings (Keywords): Animals, Astrocytes, Cell Communication, Cells, Cultured, Demyelinating Diseases, Leukodystrophy, Globoid Cell, Male, Mice, Mice, Inbred C57BL, Mice, Neurologic Mutants, Mice, Transgenic, Microglia, Prostaglandin D2


Check for Full Text / PubMed Unique Identifier (PMID): 16624958


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.